Imaging Endpoints Appoints Elliot Fishman To Scientific Advisory Board
World-Class Radiologist To Help Guide Imaging Efforts
News provided by
Share this article
Share this article
SCOTTSDALE, Ariz., Jan. 13, 2021 /PRNewswire/ Imaging Endpoints announced today Elliot K. Fishman, MD, the Elliot K. Fishman Professor in Radiology at Johns Hopkins, has been appointed to its prestigious Scientific Advisory Board.
Elliot Fishman is currently the Director of Diagnostic Imaging and Body Computed Tomography (CT) in the Russell H. Morgan Department of Radiology and Radiological Science, and Professor of Radiology, Surgery, Oncology and Urology at Johns Hopkins. Additionally, he serves as co-principal investigator of the Felix Project for Early Detection of Pancreatic Cancer, focused on using deep learning and artificial intelligence for medical imaging.
Compound derived from thunder god vine could improve outcomes for pancreatic cancer patients
The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest how a compound derived from the thunder god vine an herb used in China for centuries to treat joint pain, swelling and fever is able to kill cancer cells and potentially improve clinical outcomes for patients with pancreatic cancer.
The medicinal plant s key ingredient, triptolide, is the basis of a water-soluble prodrug called Minnelide, which appears to attack pancreatic cancer cells and the cocoon of stroma surrounding the tumor that shields it from the body s immune system. Investigators recently published the study results in the journal
E-Mail
PHOENIX, Ariz. Dec. 14, 2020 The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest how a compound derived from the thunder god vine an herb used in China for centuries to treat joint pain, swelling and fever is able to kill cancer cells and potentially improve clinical outcomes for patients with pancreatic cancer.
The medicinal plant s key ingredient, triptolide, is the basis of a water-soluble prodrug called Minnelide, which appears to attack pancreatic cancer cells and the cocoon of stroma surrounding the tumor that shields it from the body s immune system. Investigators recently published the study results in the journal